Search research articles
Contact Us
Filters
Showing results (151-160 of 316) with videos related to
Page
of 32
Sort By:
Cancer Genetics and Cytogenetics
|
May 18, 1999
Characterization of drug-resistant cell lines by comparative genomic hybridization
K M Carlson, A Gruber, E Liliemark, et al.
Biomaterials
|
February 1, 1993
Complement activation by polymethyl methacrylate minimized by end-point heparin attachment
M Pekna, R Larsson, B Formgren, et al.
Journal of Chemical Theory and Computation
|
June 24, 2020
Minimal Matrix Product States and Generalizations of Mean-Field and Geminal Wave Functions
Henrik R Larsson, Carlos A Jiménez-Hoyos, Garnet Kin-Lic Chan
The American Journal of Physiology
|
June 1, 1983
Interactions between magnesium and calcium in beta-cell-rich pancreatic islets
P O Berggren, P Bergsten, E Gylfe, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
May 8, 2007
Primary lymphocytes as predictors for species differences in cytotoxic drug sensitivity
S B Hassan, C Haglund, A Aleskog, et al.
Biomaterials
|
November 1, 1987
Long-term stability in vivo of a thromboresistant heparinized surface
C Arnander, D Bagger-Sjöbäck, S Frebelius, et al.
Calcified Tissue International
|
January 1, 1997
A new fluorometric assay for determination of osteoblastic proliferation: effects of glucocorticoids and insulin-like growth factor-I
K B Jonsson, A Frost, R Larsson, et al.
Upsala Journal of Medical Sciences
|
November 30, 2000
Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes
W Bennet, C G Groth, R Larsson, et al.
Biomaterials
|
August 21, 2001
Binding of a model regulator of complement activation (RCA) to a biomaterial surface: surface-bound factor H inhibits complement activation
J Andersson, R Larsson, R Richter, et al.
Clinical Pharmacology and Therapeutics
|
February 18, 1998
A general model for time-dissociated pharmacokinetic-pharmacodynamic relationship exemplified by paclitaxel myelosuppression
M O Karlsson, V Molnar, J Bergh, et al.
Page
of 32
Search research articles
Search
Showing results (151-160 of 316) with videos related to
Sort By:
Page
of 32
Cancer Genetics and Cytogenetics
|
May 18, 1999
Characterization of drug-resistant cell lines by comparative genomic hybridization
K M Carlson, A Gruber, E Liliemark, et al.
Biomaterials
|
February 1, 1993
Complement activation by polymethyl methacrylate minimized by end-point heparin attachment
M Pekna, R Larsson, B Formgren, et al.
Journal of Chemical Theory and Computation
|
June 24, 2020
Minimal Matrix Product States and Generalizations of Mean-Field and Geminal Wave Functions
Henrik R Larsson, Carlos A Jiménez-Hoyos, Garnet Kin-Lic Chan
The American Journal of Physiology
|
June 1, 1983
Interactions between magnesium and calcium in beta-cell-rich pancreatic islets
P O Berggren, P Bergsten, E Gylfe, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
May 8, 2007
Primary lymphocytes as predictors for species differences in cytotoxic drug sensitivity
S B Hassan, C Haglund, A Aleskog, et al.
Biomaterials
|
November 1, 1987
Long-term stability in vivo of a thromboresistant heparinized surface
C Arnander, D Bagger-Sjöbäck, S Frebelius, et al.
Calcified Tissue International
|
January 1, 1997
A new fluorometric assay for determination of osteoblastic proliferation: effects of glucocorticoids and insulin-like growth factor-I
K B Jonsson, A Frost, R Larsson, et al.
Upsala Journal of Medical Sciences
|
November 30, 2000
Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes
W Bennet, C G Groth, R Larsson, et al.
Biomaterials
|
August 21, 2001
Binding of a model regulator of complement activation (RCA) to a biomaterial surface: surface-bound factor H inhibits complement activation
J Andersson, R Larsson, R Richter, et al.
Clinical Pharmacology and Therapeutics
|
February 18, 1998
A general model for time-dissociated pharmacokinetic-pharmacodynamic relationship exemplified by paclitaxel myelosuppression
M O Karlsson, V Molnar, J Bergh, et al.
Page
of 32